NYSE - Delayed Quote • USD
Compare
At close: August 16 at 4:00 PM EDT
After hours: August 16 at 6:15 PM EDT
Line
Candle
Baseline
Mountain
Bar
Loading Chart for A
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
139.89 - Open
139.79 - Bid 138.50 x 900
- Ask 142.69 x 1300
- Day's Range
138.52 - 140.90 - 52 Week Range
96.80 - 155.35 - Volume
1,284,804 - Avg. Volume
2,092,527 - Market Cap (intraday)
40.858B - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
33.18 - EPS (TTM)
4.22 - Earnings Date Aug 21, 2024
- Forward Dividend & Yield 0.94 (0.67%)
- Ex-Dividend Date Jul 2, 2024
- 1y Target Est
139.38
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
17,600
Full Time Employees
October 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Agilent Technologies, Inc.
Recent News: A
View MoreAll SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: A
Trailing total returns as of 8/16/2024, which may include dividends or other distributions. Benchmark is
YTD Return
A
1.08%
S&P 500
16.45%
1-Year Return
A
12.26%
S&P 500
25.16%
3-Year Return
A
10.29%
S&P 500
24.31%
5-Year Return
A
108.41%
S&P 500
95.05%
Compare To: A
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
140.04
+0.11%
Mkt Cap 40.858B
Industry Diagnostics & Research
339.98
-0.21%
Mkt Cap 20.182B
Industry Diagnostics & Research
603.98
+0.05%
Mkt Cap 230.718B
Industry Diagnostics & Research
269.32
-0.00%
Mkt Cap 194.506B
Industry Diagnostics & Research
1,417.58
-1.20%
Mkt Cap 30.08B
Industry Diagnostics & Research
Mkt Cap 10.423B
Industry Diagnostics & Research
151.38
+1.13%
Mkt Cap 16.851B
Industry Diagnostics & Research
227.50
+1.31%
Mkt Cap 19.102B
Industry Diagnostics & Research
492.26
+1.39%
Mkt Cap 40.516B
Industry Diagnostics & Research
239.63
-0.53%
Mkt Cap 43.685B
Industry Diagnostics & Research
123.98
+1.42%
Mkt Cap 15.334B
Industry Diagnostics & Research
Statistics: A
View More
Valuation Measures
As of 8/16/2024
Market Cap
40.86B
Enterprise Value
41.74B
Trailing P/E
33.18
Forward P/E
24.33
PEG Ratio (5yr expected)
3.01
Price/Sales (ttm)
6.26
Price/Book (mrq)
6.58
Enterprise Value/Revenue
6.33
Enterprise Value/EBITDA
24.92
Financial Highlights
Profitability and Income Statement
Profit Margin
18.84%
Return on Assets (ttm)
7.82%
Return on Equity (ttm)
20.71%
Revenue (ttm)
6.59B
Net Income Avi to Common (ttm)
1.24B
Diluted EPS (ttm)
4.22
Balance Sheet and Cash Flow
Total Cash (mrq)
1.67B
Total Debt/Equity (mrq)
43.87%
Levered Free Cash Flow (ttm)
924.25M
Research Analysis: A
View MorePeople Also Watch
KEYS Keysight Technologies, Inc.
135.30
+1.98%
HPQ HP Inc.
35.91
+1.18%
ADI Analog Devices, Inc.
223.19
-0.21%
JNPR Juniper Networks, Inc.
38.86
+0.13%
TMO Thermo Fisher Scientific Inc.
603.98
+0.05%
DHR Danaher Corporation
269.32
-0.00%
NTAP NetApp, Inc.
130.50
-0.71%
TXN Texas Instruments Incorporated
200.53
-0.69%
AMAT Applied Materials, Inc.
207.90
-1.86%
KLAC KLA Corporation
819.57
-1.99%
CIEN Ciena Corporation
53.80
-0.94%
AKAM Akamai Technologies, Inc.
100.50
-0.36%
GLW Corning Incorporated
40.20
-0.15%
BAX Baxter International Inc.
36.12
+1.09%
WAT Waters Corporation
339.98
-0.21%
BDX Becton, Dickinson and Company
236.33
+0.99%